In this in vitro study, we demonstrated that genetically delivered IL-15/IL-15Rα modulates the composition and activation of melanoma surrounding immune cells and elicits immune cell-mediated anti-tumor immune responses. This evidence concerns the gene IL15RA and melanoma.